
Home - MgShell
MgShell aspires to inspire a change in ophthalmology. We have developed a magnesium-based drug delivery platform capable of reshaping patient care, enhancing treatment adherence for …
About Us - MgShell
At MgShell, our shared vision and mission unite everyone within the company. We are dedicated to redefining ophthalmology. Our mission is to drive healthcare innovation by introducing a …
MgShell - Capital Cell
Founded by an expert team that includes bioengineers and a retinal specialist, MgShell has developed i3D, an intravitreal drug delivery platform that uses magnesium for controlled drug …
Technology - MgShell
MgShell aspires to inspire a change in ophthalmology. We have developed a magnesium-based drug delivery platform capable of reshaping patient care, enhancing treatment adherence for …
MgShell - Crunchbase Company Profile & Funding
MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating …
MgShell - F6S
MgShell aims to revolutionize the therapeutic approach in the ophthalmological field. The company goal arises from the need to solve the issues associated to patients suffering from …
British Classic MGB Roadster bodyshells - British Motor Heritage
MGB Roadster bodyshells are manufactured by using original factory press tooling and assembly jigs. They represent the most economical and accurate method of restoring a car. All …
MgShell | Capital Cell
En MgShell desarrollamos soluciones innovadoras para mejorar el tratamiento de la degeneración macular asociada a la edad (DMAE), una de las principales causas de ceguera …
MgShell - VentureRadar
Develops i3D, a biodegradable intraocular drug-delivery device for maculopathy patients, increasing compliance, reducing healthcare costs, and benefiting pharmaceutical companies. …
MgShell secures over €850,000 in investments to advance ocular …
2024年12月2日 · Milan, Italy (November 30, 2024) Today, MgShell, a MedTech company that aspires to inspire a change in ophthalmology by developing a magnesium-based drug delivery …